SCHEMBL25535202

SCHEMBL25535202

c1ccc(-c2ccc(-c3cc(-c4cccc5c4sc4ccccc45)nc(-c4ccc(-c5ccc6c(c5)-c5ccccc5C6(c5ccccc5)c5ccccc5)c5ccccc45)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
MAPT P10636 3/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
GAA P10253 1/20 0.31
CYP2C9 P11712 1/20 0.31
AGTR1 P30556 1/20 0.31
CYP2C19 P33261 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MEN1 O00255 2/20 0.30
ALDH1A1 P00352 2/20 0.30
HPGD P15428 2/20 0.30
KMT2A Q03164 2/20 0.30
PRKDC P78527 1/20 0.30
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25534920 0.95 ALOX5 (0.41) ALOX5MAPTCYP1A2CYP3A4GAA
SCHEMBL25534993 0.92 ALOX5 (0.41) ALOX5MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL25535062 0.91 ALOX5 (0.37) ALOX5MAPTMEN1ALDH1A1HPGD
SCHEMBL25535126 0.91 ALOX5 (0.39) ALOX5MAPTMEN1ALDH1A1HPGD
SCHEMBL27255271 0.89 ALOX5 (0.40) ALOX5MAPTCYP1A2CYP3A4GAA
SCHEMBL25534013 0.89 ALOX5 (0.41) ALOX5MAPTMEN1ALDH1A1HPGD
SCHEMBL25535211 0.89 PIM3 (0.32) MAPTSMN1; SMN2MEN1ALDH1A1HPGD
SCHEMBL25535205 0.89 MAPT (0.32) MAPTSMN1; SMN2MEN1ALDH1A1HPGD
SCHEMBL25534657 0.88 ALOX5 (0.42) ALOX5MAPTMEN1ALDH1A1HPGD
SCHEMBL24993437 0.87 ALOX5 (0.41) ALOX5MAPTCYP1A2CYP3A4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ALOX5 1908/4885MAPT 1595/4885CYP1A2 1590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.